WO2014045263A3 - Procédé de préparation d'intermédiaires du télaprévir - Google Patents
Procédé de préparation d'intermédiaires du télaprévir Download PDFInfo
- Publication number
- WO2014045263A3 WO2014045263A3 PCT/IB2013/058808 IB2013058808W WO2014045263A3 WO 2014045263 A3 WO2014045263 A3 WO 2014045263A3 IB 2013058808 W IB2013058808 W IB 2013058808W WO 2014045263 A3 WO2014045263 A3 WO 2014045263A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- telaprevir
- intermediates
- octahydrocyclopenta
- pyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/20—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/44—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
- C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic
- C07C35/06—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring monocyclic containing a five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
Abstract
La présente demande de brevet concerne des procédés inédits de préparation d'acide (1S,3a R,6a S)-octahydrocyclopenta[c]pyrrole-1-carboxylique et de ses dérivés, ainsi que leur utilisation dans le cadre de la préparation du télaprévir.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3962CH2012 | 2012-09-24 | ||
IN3962/CHE/2012 | 2012-09-24 | ||
IN340CH2013 | 2013-01-24 | ||
IN340/CHE/2013 | 2013-01-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014045263A2 WO2014045263A2 (fr) | 2014-03-27 |
WO2014045263A3 true WO2014045263A3 (fr) | 2014-05-15 |
Family
ID=50342032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2013/058808 WO2014045263A2 (fr) | 2012-09-24 | 2013-09-24 | Procédé de préparation d'intermédiaires du télaprévir |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014045263A2 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018369A2 (fr) * | 2000-08-31 | 2002-03-07 | Eli Lilly And Company | Inhibiteurs peptidomimetiques de protease |
WO2008106130A2 (fr) * | 2007-02-26 | 2008-09-04 | Achillion Pharmaceuticals, Inc. | Peptides substitués par une amine tertiaire utiles comme inhibiteurs de la réplication du virus de l'hépatite c |
US20100041674A1 (en) * | 2008-08-15 | 2010-02-18 | Avila Therapeutics, Inc. | Hcv protease inhibitors and uses thereof |
JP2013010738A (ja) * | 2011-05-31 | 2013-01-17 | Sumitomo Chemical Co Ltd | エステル化合物の製造方法 |
-
2013
- 2013-09-24 WO PCT/IB2013/058808 patent/WO2014045263A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002018369A2 (fr) * | 2000-08-31 | 2002-03-07 | Eli Lilly And Company | Inhibiteurs peptidomimetiques de protease |
WO2008106130A2 (fr) * | 2007-02-26 | 2008-09-04 | Achillion Pharmaceuticals, Inc. | Peptides substitués par une amine tertiaire utiles comme inhibiteurs de la réplication du virus de l'hépatite c |
US20100041674A1 (en) * | 2008-08-15 | 2010-02-18 | Avila Therapeutics, Inc. | Hcv protease inhibitors and uses thereof |
JP2013010738A (ja) * | 2011-05-31 | 2013-01-17 | Sumitomo Chemical Co Ltd | エステル化合物の製造方法 |
Non-Patent Citations (1)
Title |
---|
KOEHLER, VALENTIN ET AL.: "Enantioselective Biocatalytic Oxidative Desymmetrization of Substituted Pyrrolidines", ANGEW. CHEM. INT. ED., 2010, vol. 49, no. 12, 9 February 2010 (2010-02-09), pages 2182 - 2184 * |
Also Published As
Publication number | Publication date |
---|---|
WO2014045263A2 (fr) | 2014-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014014835A3 (fr) | Formes cristallines d'un inhibiteur de la prolyl hydroxylase | |
SG11201502622VA (en) | PYRROLO[3,2-<i>D</i>]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS AND OTHER DISEASES | |
WO2012149299A3 (fr) | Procédés de traitement du cancer et de maladies inflammatoires au moyen de céréblon en tant que prédicteur | |
WO2013119960A3 (fr) | Nouveaux modulateurs et procédés d'utilisation | |
EP3778606A3 (fr) | Imidazolylimidazoles condensés en tant que composés antiviraux | |
EP3060237A4 (fr) | Procédés, systèmes et compositions associés à une conversion de cellules par l'intermédiaire d'une reprogrammation cellulaire in-vivo induite par protéines | |
WO2012074818A3 (fr) | Compositions et procédés pour la production d'acide 3-hydroxypropionique | |
WO2012129341A3 (fr) | Détection d'une maladie chez les plantes | |
EA201492165A1 (ru) | Синтез пирроло[2,3-b]пиридинов | |
SG178991A1 (en) | Anti-gitr antibodies | |
WO2012024427A3 (fr) | Cellules facilitantes humaines et utilisations associées | |
WO2012139134A3 (fr) | Procédés de modulation des protéines de fusion oncogènes | |
ZA201306545B (en) | 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of betasecretase (bace) | |
ZA201401562B (en) | Agrochemical composition uses and preparation process thereof, as well as method to ensure high crop yield | |
AU2011360938A8 (en) | Novel modulators and methods of use | |
WO2013006547A3 (fr) | Anticorps dirigés contre le récepteur du facteur de croissance épidermique (egfr) et leurs utilisations | |
WO2012155066A3 (fr) | Agonistes de mdm2 consistant en spiro-oxindoles | |
NZ630222A (en) | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | |
WO2012087160A3 (fr) | Protéines anti-inflammatoires et procédés de préparation et d'utilisation de celles-ci | |
WO2014093505A3 (fr) | Production médiée par acp de dérivés d'acides gras | |
WO2012109605A3 (fr) | Formes de rifaximine et leurs utilisations | |
CR20150577A (es) | Formulaciones farmacéuticas, proceso, formas sólidas y métodos de uso relacionados con 1-etil-7-(2-metil-6-(1h-1,2,4-triazol-3-ii) piridin-3-ii)-3,4-dihidropirazino [2,3-b] pirazin-2 (1h)-ona | |
WO2012154983A3 (fr) | Systèmes et procédés pour des anticorps anti-pax8 | |
WO2011079193A3 (fr) | Préparation de la bendamustine et de ses sels | |
WO2012054929A3 (fr) | Utilisation d'albumine sérique humaine pour diminuer l'immunogénicité de protéines thérapeutiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13838697 Country of ref document: EP Kind code of ref document: A2 |